<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885075</url>
  </required_header>
  <id_info>
    <org_study_id>No.F.1-1/2015/ERB/SZABMU/602</org_study_id>
    <nct_id>NCT04885075</nct_id>
  </id_info>
  <brief_title>Comparing the Efficacy of Intranasal Midazolam Versus Intravenous Diazepam for Control of Seizures in Children</brief_title>
  <official_title>A Randomized Controlled Trial Comparing the Efficacy of Intranasal Midazolam and Conventional Treatment With Intravenous Diazepam for Control of Seizures in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaheed Zulfiqar Ali Bhutto Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaheed Zulfiqar Ali Bhutto Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      After approval , study will be conducted at the Children Hospital PIMS, Islamabad. Children&#xD;
      1-12 years presenting/admitted with seizures will be enrolled in the study after taking&#xD;
      informed consent from the parents. Children's name, age, sex will be recorded by the on duty&#xD;
      doctor. Patients will be randomly allocated to two equal groups. Group A (GA) will receive&#xD;
      single dose of intravenous diazepam (0.2mg/kg/dose)after passing cannula, while Group B (GB)&#xD;
      will receive single dose of intranasal midazolam (0.2mg/kg/dose).Response to treatment will&#xD;
      be assessed by recording the time required for termination of seizures in both gruops.the&#xD;
      time required for gaining intravenous accessin Group A will be recorded as well. Data will be&#xD;
      collected through a structured performa.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Benzodiazepines are the first line of drugs for cessation of acute seizures.benzodizepines&#xD;
      can be given intravenous,orally,per rectal and intranasal.Conventional treatment of acute&#xD;
      seizures is intravenous diazepam in most hospital settings which requires an IV access,which&#xD;
      is not possible for parents to give at home.The main problem in an actively seizuring child&#xD;
      is to reach the hospital and maintaining an intravenous line.Midazolam is a water soluble&#xD;
      benzodiazepine which is widely used as an anxiolytic and anticonvulsant ,can be given through&#xD;
      intravenously,intramuscularly, oral,buccal and nasal mucosa as well.it becomes lipid soluble&#xD;
      at physiologic PH levels and reaches the CNS with a rapid onset and shorter duration of&#xD;
      action.It is administered into nostril in a way that it comes into direct contact with nasal&#xD;
      mucosa.It is given in a dose of 0.2mg\kg and within a few minutes its level in serum are&#xD;
      comparable to the injectables levels.It is a safe,cheap,easy to use and effective alternative&#xD;
      to diazepam for use at home as well as in hospital settings.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 30, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time taken for seizures to be controlled</measure>
    <time_frame>From administration of drug to the cessation of seizures up to 10 minutes</time_frame>
    <description>Intranasal midazolam will take less time for cessation of seizure than intravenous diazepam</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Seizures</condition>
  <arm_group>
    <arm_group_label>Intravenous Diazepam</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intravenous diazepam (0.2mg/kg/dose) single dose stat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intranasal Midazolam</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intranasal midazolam (0.2mg/kg/dose) single dose stat</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV diazepam</intervention_name>
    <description>inj.diazepam 0.2mg/kg/dose stat</description>
    <arm_group_label>Intravenous Diazepam</arm_group_label>
    <other_name>valium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>I/N Midazolam</intervention_name>
    <description>intranasal midazolam 0.2mg/kg/dose stat</description>
    <arm_group_label>Intranasal Midazolam</arm_group_label>
    <other_name>dormicum</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children 1-10 years both male and female visiting/admitted in Children Hospital PIMS&#xD;
             with acute episode of seizure (febrile or afebrile)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children requiring emergency resuscitation&#xD;
&#xD;
          -  Children with uncontrolled epilepsy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>nighat haider, mbbs,fcps</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaheed Zulfiqar Ali Bhutto Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>zunash fateh, mbbs</last_name>
    <phone>03344360704</phone>
    <email>zunash.ammar@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>nighat haider, mbbs,fcps</last_name>
    <phone>03361422244</phone>
    <email>nighathaider@hotmail.com</email>
  </overall_contact_backup>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shaheed Zulfiqar Ali Bhutto Medical University</investigator_affiliation>
    <investigator_full_name>Dr Nighat Haider</investigator_full_name>
    <investigator_title>assistant professor of paediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Diazepam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

